Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.57 -0.02 (-1.26%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$1.60 +0.03 (+1.91%)
As of 09/12/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs. Its Competitors

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

In the previous week, Orthofix Medical had 4 more articles in the media than Accuray. MarketBeat recorded 7 mentions for Orthofix Medical and 3 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.53 beat Accuray's score of 0.64 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accuray
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Accuray has a net margin of -0.35% compared to Orthofix Medical's net margin of -15.29%. Accuray's return on equity of -4.92% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray-0.35% -4.92% -0.58%
Orthofix Medical -15.29%-25.43%-14.46%

Accuray presently has a consensus price target of $5.00, suggesting a potential upside of 218.47%. Orthofix Medical has a consensus price target of $21.50, suggesting a potential upside of 44.20%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

Accuray has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

64.1% of Accuray shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 4.2% of Accuray shares are held by company insiders. Comparatively, 1.3% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$458.51M0.39-$1.59M-$0.02-78.50
Orthofix Medical$799.49M0.74-$126M-$3.17-4.70

Summary

Accuray and Orthofix Medical tied by winning 8 of the 16 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$176.90M$6.78B$5.78B$10.18B
Dividend YieldN/A1.20%5.73%4.60%
P/E Ratio-78.5026.0175.4626.03
Price / Sales0.39187.86466.5092.26
Price / Cash35.2222.1825.8129.91
Price / Book2.185.0012.166.25
Net Income-$1.59M$176.38M$3.29B$270.76M
7 Day Performance1.29%0.64%0.73%2.54%
1 Month Performance12.14%2.47%4.41%5.73%
1 Year Performance-28.31%10.96%62.61%25.85%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
4.7317 of 5 stars
$1.57
-1.3%
$5.00
+218.5%
-28.3%$176.90M$458.51M-78.501,040Analyst Upgrade
High Trading Volume
OFIX
Orthofix Medical
3.4879 of 5 stars
$14.70
+1.0%
$21.50
+46.3%
-11.0%$574.64M$799.49M-4.641,616Positive News
SRDX
Surmodics
4.553 of 5 stars
$32.93
+1.7%
$43.00
+30.6%
-18.8%$462.96M$126.08M-26.77450Positive News
ANGO
AngioDynamics
4.1629 of 5 stars
$10.90
+1.6%
$19.00
+74.3%
+39.4%$436M$292.50M-13.13760Positive News
RMTI
Rockwell Medical
3.8859 of 5 stars
$1.59
-1.9%
$4.00
+151.6%
-58.2%$55.78M$87.97M-26.50300News Coverage
Positive News
Short Interest ↑
RSLS
ReShape Lifesciences
0.0154 of 5 stars
$3.16
-1.4%
N/A-99.7%$8.49M$8.01M-0.0350Positive News
Gap Down
High Trading Volume
ABT
Abbott Laboratories
4.9054 of 5 stars
$132.27
-0.5%
$144.47
+9.2%
+15.1%$231.38B$41.95B16.58114,000Positive News
ISRG
Intuitive Surgical
4.9313 of 5 stars
$470.00
+0.7%
$595.95
+26.8%
-8.2%$167.36B$8.35B65.5515,638News Coverage
Positive News
BSX
Boston Scientific
4.7786 of 5 stars
$108.14
+0.9%
$117.79
+8.9%
+23.3%$158.87B$16.75B64.3753,000Trending News
SYK
Stryker
4.9341 of 5 stars
$393.12
+0.2%
$430.10
+9.4%
+3.5%$149.98B$22.60B52.0753,000Positive News
MDT
Medtronic
4.9292 of 5 stars
$92.91
+0.0%
$102.14
+9.9%
+4.5%$119.16B$33.54B25.5995,000Positive News

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners